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FOG-2, a Cofactor for GATA Transcription Factors,
Is Essential for Heart Morphogenesis and
Development of Coronary Vessels from Epicardium
in appearance (Kuo et al., 1997; Molkentin et al., 1997).
Disruption of the GATA-6 gene leads to early lethality
at embryonic day (E) E6.5±7.5 due to impaired extraem-
bryonic endoderm development (Morrisey et al., 1998).
Despite indirect evidence linking GATA-4/5/6 to tran-
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Transcriptional activities of GATA factors are modu-Department of Medicine
Beth Israel Deaconess Medical Center lated through physical interaction with other transcrip-
tion factors (FOG-1, PU-1, Pit-1, NKX2.5, NF-AT3, andHarvard Medical School and
Howard Hughes Medical Institute CBP/p300). The best characterized among these inter-
actions is that between GATA-1 and FOG-1 (friend ofBoston, Massachusetts 02115
GATA-1), a protein first sought as a cell-restricted cofac-
tor for GATA-1 in erythroid cell differentiation. The asso-
ciation of FOG-1 with GATA-1 is mediated through theSummary
amino-finger of GATA-1 (Tsang et al., 1997). Analysis of
altered specificity mutants of both GATA-1 and FOG-1We disrupted the FOG-2 gene in mice to define its
requirement in vivo. FOG-22/2 embryos die at midges- (Crispino et al., 1999), as well as a study of patients with
mutations in GATA-1 (Nichols et al., 2000), establishestation with a cardiac defect characterized by a thin
ventricular myocardium, common atrioventricular ca- the in vivo relevance of the GATA-1:FOG-1 interaction
for erythroid and megakaryocytic differentiation. Con-nal, and the tetralogy of Fallot malformation. Remark-
ably, coronary vasculature is absent in FOG-22/2 sistent with these conclusions, genetic ablation of FOG-1
in mice leads to arrested erythroid differentiation, re-hearts. Despite formation of an intact epicardial layer
and expression of epicardium-specific genes, markers sembling loss of GATA-1 itself. A more extreme mega-
karyocyte defect in the absence of FOG-1 points toof cardiac vessel development (ICAM-2 and FLK-1)
are not detected, indicative of failure to activate their additional GATA-1-independent role(s) for FOG-1 in this
lineage (Tsang et al., 1998). Taken together, these dataexpression and/or to initiate the epithelial to mesen-
chymal transformation of epicardial cells. Transgenic define an essential role for FOG-1 as a primary cofactor
for GATA-1 and yet allow for autonomous roles for eachreexpression of FOG-2 in cardiomyocytes rescues the
FOG-22/2 vascular phenotype, demonstrating that protein.
Determinants of the GATA-1:FOG interactions areFOG-2 function in myocardium is required and suffi-
cient for coronary vessel development. Our findings conserved in the amino-finger of all GATA factors. To
explore further the role of FOG-like proteins, we andprovide the molecular inroad into the induction of cor-
onary vasculature by myocardium in the developing others isolated a second FOG protein, FOG-2, which is
expressed predominantly in cardiac and nervous tissuesheart.
(Lu et al., 1999; Tevosian et al., 1999; Svensson et al.,
1999). Nonetheless, FOG-2 substitutes for FOG-1 in res-Introduction
cue of erythroid differentiation in FOG-12/2 hematopoi-
etic cells, thereby pointing to shared functions of FOGGATA transcription factors serve critical roles in devel-
proteins (Tevosian et al., 1999). Also, FOG-2 physicallyopment. The six vertebrate GATA factors fall into two
interacts with GATA-4/5/6. Thus, it is a strong candidatesubfamilies (GATA-1/2/3 and GATA-4/5/6). GATA-1/2/3
to serve as a cofactor for any, or all, of these proteinsare expressed in the hematopoietic system, plus other
in heart and/or brain development. Indeed, transientspecific sites (reviewed by Orkin, 1998). Gene targeting
transfection assays in primary cardiac cells suggest thatexperiments have demonstrated an essential role for
FOG-2 may either enhance (Lu et al., 1999) or repressGATA-1 in erythroid and megakaryocytic lineage differ-
(Lu et al., 1999; Svensson et al., 1999) GATA-4's tran-entiation, GATA-2 in hematopoietic stem cell and mast
scriptional activity. A function for FOG-2 in the nervouscell development, and GATA-3 in early T-lymphoid cell
system may be inferred from repression of the Drosoph-development and generation of Th2 cells. Members of
ila GATA factor pannier by a FOG-like protein, u-shaped,the GATA-4/5/6 subfamily are expressed in an overlap-
in control of proneural genes in Drosophila (Cubadda etping and dynamic fashion, principally within the heart
al., 1997).and the gastrointestinal tract (for review, see Parmacek
To determine the in vivo requirement for FOG-2 inand Leiden, 1999; Charron and Nemer, 1999; Gao et al.,
development, we have now generated gene-targeted1998). Loss of GATA-4 in the mouse interrupts ventral
mice. Absence of FOG-2 is embryonic lethal due to con-morphogenesis leading to cardia bifida and embryonic
sistent defects in heart morphogenesis, including ven-death; GATA-52/2 mice are viable and grossly normal
tricular hypoplasia, a common atrioventricular canal,
and the constellation of findings associated with the§ To whom correspondence should be addressed (e-mail: orkin@
rascal.med.harvard.edu). tetralogy of Fallot malformation of humans. Of particular
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additional interest is an early block in formation of coro-
nary vessels in FOG-22/2 mice. Normally, epicardial
cells, originating from the proepicardial organ, undergo
an epithelial-to-mesenchymal transition to give rise to
the subepicardial coronary vasculature. Despite forma-
tion of an intact epicardial layer and expression of epi-
cardium-specific genes in FOG-22/2 heart, markers of
cardiac vessel development (ICAM-2 and FLK-1) are
not detected. We postulate that the inability to activate
FLK-1 and ICAM-2 expression and to produce epicar-
dial-derived cells (EPDCs) reflects a failure to initiate or
sustain this transition. To determine where FOG-2 is
required in these processes, we performed chimera and
transgenic rescue experiments. Our findings define an
essential FOG-2-dependent role for myocardium in the
program of coronary vessel development.
Results
Embryonic Lethality of FOG-22/2 Mice
To inactivate the FOG-2 gene, sequences encoding all
zinc-fingers of the protein were replaced with a floxed
neomycin-cytidine deaminase (CD) cassette in ES cells
(Figure 1A). The CD cassette was removed by inter-
breeding with a Cre recombinase-deleter strain (Mao et
al., 1999). Southern blotting (Figure 1B) of timed matings
revealed death of FOG-22/2 embryos between E12.5±
15.5. By E13.5, some FOG-22/2 mice had died; at E14.5
about half were necrotic and undergoing resorption. No
differences were observed between two independently
targeted mouse lines, as well as between strains with Figure 1. Targeted Disruption of the mFOG-2 Gene
or without the CD selection cassette. Absence of intact
(A) FOG-2 wild-type locus (top), targeting construct (middle), and
FOG-2 mRNA in FOG2/2 heart tissue was confirmed by targeted homologous recombination at the FOG-2 locus before and
RNase protection assay and RT-PCR analysis (Figure after Cre-mediated excision of the selection cassettes (bottom). The
targeting construct (pTKLNCL) contains HSV-TK, neomycin resis-1C; data not shown).
tance (PGK::neo), and cytidine deaminase (PGK::cyto) cassettes.
Homologous recombination removes exon sequences encoding allComplex Cardiac Defects Including Tetralogy
fingers (z) of FOG-2. The probe used in Southern blotting is shown
of Fallot in FOG-22/2 Mice as a black bar; the position of the RNase protection probe is shown
At E12.5, FOG-22/2 embryos were grossly normal in ap- as an empty bar. Triangles represent loxP sites.
pearance. By E13.5, mutants were pale and edematous (B) Southern blot analysis of E12.5 embryos resulting from an in-
tercross of FOG-21/2neo-cd (I) or FOG-21/2 (II) mice, demonstrating(Figures 2A±2D). Peripheral hemorrhage was often ob-
the presence of expected genotypes. WT, wild-type allele; Mut(neo)served. The overall appearance was that of heart failure.
and Mut, mutant alleles before and after Cre-mediated excision,Mutant hearts had markedly dilated atria and appeared
respectively.
rounder than normal since sharp ventricular apicies (C) RNase protection analysis of FOG-2 RNA (top) and 28S rRNA
were absent (Figures 2E and 2G). Pulsation of mutant (bottom) transcripts in E12.5 hearts of wild-type, heterozygous, and
hearts was slower and feeble; blood cells remained homozygous FOG-2 mutant embryos. Positions of protected frag-
ments are indicated. Nonspecific protected fragments derived fromwithin the heart even after contraction. Notably, bleeding
the FOG-2 probe are also present in the control lane containingaround the heart was not observed.
yeast tRNA (ytRNA) (asterisk).Hearts of control and mutant embryos at E13.5±15.0
were compared microscopically (Figures 2E±2I). FOG-22/2
hearts were distinguished by thinning of compact ven- Other malformations observed in FOG-22/2 embryos,
such as underdevelopment of lungs and smaller livertricular myocardium (Figure 2F), which resembles a
ªpapyraceous phenotypeº (Lee et al., 1997) reported size, appeared secondary to cardiac failure.
previously (see Discussion). Atria also appeared thin
with sparse trabeculae. In addition, FOG-22/2 embryos Molecular Analysis of FOG-22/2 Myocardium
FOG proteins modulate activity of GATA factors andexhibited defects seen in the human congenital malfor-
mation tetralogy of Fallot: atrial septal defect, overriding thereby influence transcription of GATA-target genes.
In myocardial cells, several genes containing GATA sitesaorta, subpulmonic stenosis, and subaortic ventricular
septal defect (VSD) (Figures 2F, 2G, and 2I) (Van Praagh, in critical regulatory regions have been proposed as
possible targets. FOG-2 augments or inhibits GATA-4-1989). The VSD appeared to be a part of a complete
common atrioventricular (AV) canal (Figure 2F). Fibrous mediated transactivation of several cardiac promoters
in transient transfection assays (Lu et al., 1999; Svens-continuity was present between the single atrioventricu-
lar valve of the common AV canal and the aortic valve. son et al., 1999).
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Figure 2. Cardiac Defects in FOG-22/2 Em-
bryos
(A and B) Wild-type (A) and mutant (B) em-
bryos at E13.5 with yolk sac and ectoplacen-
tal cone intact.
(C and D) Wild-type (C) and mutant (D) em-
bryos at E13.5 showing edema and peripheral
bleeding in a mutant.
(E and F) Transverse sections of wild-type (E)
and mutant (F) hearts at E14.5 at the level
of the atrioventricular (AV) junction show
enlarged atria, thin compact myocardium
(arrow), and common AV valve (asterisk)
opening in the LV in a mutant (F). The mitral
and tricuspid valves in the wild-type heart (E)
are indicated by arrowheads. The insets show
high-power magnification of boxed segments
of left ventricular walls (2003).
(G) Transverse section of a mutant embryo at
E14.5 illustrating a ventricular septal defect
(arrowhead).
(H and I) Sections of a wild-type (H) and a
mutant (I) E15.0 embryo showing severely ob-
structed pulmonary trunk (PT) in the mutant.
Ao, aorta; AVv, atrioventricular valve; LA, left
atrium; LV, left ventricle; mv, mitral valve; RA,
right atrium; RV, right ventricle; and tv, tricus-
pid valve. Original magnification: (E, F, and
G), 403; (H and I), 1003.
To determine effects of FOG-2 loss on transcription, Hand1/Hxt/Th1 and dHand/Hand2/Hed/Th2) was osten-
sibly perturbed in mutants. In fetal heart, eHand tran-expression of numerous genes in myocardium was ex-
amined by RNA in situ hybridization at E12.5, a time scripts are at highest levels in the outer curvature of the
left and the right ventricles, as well as in the outflow tract.prior to evident cardiac failure. Midgestation death of
FOG-22/2 embryos predicted that establishment of the At this stage, dHand is highly expressed throughout the
right ventricular myocardium (see Harvey et al., 1999;program of myocardial development was largely intact.
Despite transient transfection assays indicative of FOG- Srivastava, 1999). At E12.5, eHand transcripts were visi-
bly decreased in mutant hearts as compared to controls2's involvement in their regulation, no differences in ex-
pression of atrial (ANF) and B-type (BNP) natriuretic and showed no enhancement of expression along the
outer ventricular curvatures (Figures 3Ba and 3Bb). Atfactors were observed (Figures 3Aa±3Ah). We also ob-
served no difference in transcript levels encoding sev- the same stage, dHand expression in mutants was
downregulated throughout the heart (Figure 3Bc). Ineral other molecules with established, or proposed,
functions in heart development, including the homeo- contrast, expression of CARP (cardiac-restricted an-
kyrin repeat protein) (Zou et al., 1997) was similar orproteins Nkx 2.5 and IRX-4, myosin light chains 2A and
2V, cardiac troponin I, N-myc, phospholamban, GATA-4, slightly upregulated in mutants (Figure 3Bd).
and GATA-6 (Figures 3Ai±3Ap; data not shown). Ventric-
ular thinning detected in mutants might result from di- Abnormal Coronary Vasculogenesis yet Intact
minished proliferation or enhanced apoptosis in the de- Epicardium in the FOG-22/2 Heart
veloping compact layer. Hence, we examined PCNA No histologic defects were observed in the endocardium
expression as a measure of cell proliferation and TUNEL and endocardial cushions of FOG-22/2 hearts. Immuno-
staining as an indicator of apoptosis. In neither assay staining of mutant and control hearts at E12.5 for
did we detect significant differences between wild-type PECAM-1 (platelet endothelial cell adhesion molecule-
and mutant hearts (data not shown). 1), a cell adhesion molecule expressed in endothelium
Among the genes examined, only expression of the (Baldwin et al., 1994), demonstrated an intact, elaborate
endocardial cell network, endothelial lining of the greatbasic-helix-loop helix (bHLH) Hand genes (eHand/
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Figure 3. Expression of Myocardial Cell Mark-
ers in Wild-Type and FOG-22/2 Heart at E12.5
(A) Serial sections of wild-type (a and b, e and
f, i and j, and m and o) and FOG-22/2 (c and
d, g and h, k and l, and m and p) embryos
were probed with antisense riboprobes for
the ANF (a-d), BNP (e-h), Nkx2.5 (i-l), MLC-
2A (m-n), and MLC-2V (o-p) and stained with
hematoxylin. Dark-field images (b, d, f, h, j,
and l) are shown for ANF, BNP, and Nkx2.5
probes. No significant differences in the ex-
pression of these markers were detected be-
tween the wild-type and FOG-22/2 embryos.
(B) Whole-mount RNA in situ hybridization of
eHand, dHand, and CARP in E12.5 hearts.
Expression of eHand ([a], frontal view; [b], top
view), dHand (c), and CARP mRNAs(d) in con-
trol and FOG-22/2 embryos. eHand expres-
sion in the outer myocardial layer (arrows)
and the aortic sac (arrowhead) of the control
heart is downregulated in the mutant. Slightly
enhanced expression of the CARP mRNA is
seen in the mutant.
vessels, valves, and atria. PECAM-1 staining also con- of PECAM-1 expression in epicardium-derived struc-
tures. To distinguish between these possibilities, wefirmed significant stenosis of the pulmonary outflow
analyzed the expression of two additional endothelialtract in the mutant (Figure 4Ab). Additionally, as best
cell markers, ICAM-2 and FLK-1.seen in the dorsal view of the wild-type heart (Figure
Intercellular adhesion molecule-2 (ICAM-2) is a cell4Ac), PECAM-1 staining revealed the emerging coronary
surface glycoprotein constitutively expressed in endo-capillary bed that originates from the outer, epicardial
thelial cells (Xu et al., 1992). Whereas ICAM-2 antibodycell layer (see Discussion). No similar staining was ob-
immunostaining of whole-mount heart preparations re-served in the FOG-22/2 heart (Figure 4Ad).
vealed prominent vascularization in control hearts, virtu-Since coronary vessels fail to form in mouse mutants
ally no staining was seen in mutants (Figure 5Aa andlacking an intact epicardium (Kwee et al., 1995; Yang et
5Ab). Sectioning of whole-mounts showed robust ven-al., 1995), the status of the epicardial layer of FOG-22/2
tricular staining in the wild-type heart confined to cellshearts was carefully assessed. We determined that the
residing in the epicardial and subepicardial layers (Fig-ventricular myocardium is ensheathed by a continuous
ure 5Ac). No staining was evident in mutants (Figurecell layer, histologically resembling epicardium rather
5Ad).than myocardium. This outer layer, as expected, failed to
FLK-1 (FLK-1/VEGFR-2/KDR), the principal mem-stain with antibody directed to smooth muscle a-actin
brane tyrosine kinase receptor for vascular endothelialthat stains the underlying myocardium (data not shown).
growth factor (VEGF), is essential for vascular develop-Moreover, the following endothelial/epicardial markers
ment throughout the mouse (Shalaby et al., 1995). Immu-were normally expressed in FOG-22/2 epicardium: reti-
nohistochemical detection of FLK-1 in whole-mountsnoic acid synthetic enzyme RALDH-2, TGFb binding
demonstrated intense staining in the ventricles of con-protein endoglin, and nuclear proteins capsulin/epicar-
trol hearts but none in mutant hearts (Figure 5Ba). Thedin and WT-1 (Figure 4B).
failure to detect FLK-1 expression is specific, since
FLK-1 expression appeared normal in other sites, such
Markedly Diminished ICAM-2 and FLK-1 Expression as lung tissue and the endothelial lining of the great
in the FOG-22/2 Heart vessels. Controls showed abundant FLK-1 expression
The absence of PECAM-1-expressing capillary vascula- restricted to the epicardium and the endothelium of sub-
ture in mutant hearts could signify failure to initiate for- epicardial vessels (data not shown). Conversely, in the
FOG-22/2 mutant only rare epicardial FLK-1 positivemation of coronary vessels or selective downregulation
FOG-2 and Coronary Vasculature
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cells were detected and confined to the atrioventricular
sulcus and ventricular groove where coronary vessel
formation is normally initiated (data not shown).
Whole-mount immunoassay detected little, if any,
ICAM-2 or FLK-1 staining in endocardial cells of control
and mutant hearts. Failure to detect these endothelial
markers in endocardium could reflect either poor pene-
tration of antibody in whole-mount samples or the exis-
tence of posttranscriptional regulation (Waltenberger et
al., 1996). To provide independent assessment of FLK-1
expression at the RNA rather than protein level, we in-
terbred FOG-2 heterozygotes with mice harboring a lacZ
knockin at the FLK-1 locus (Shalaby et al., 1995). Doubly
heterozygous animals were then back-crossed to FOG-2
heterozygotes. Offspring were genotyped and analyzed
for lacZ expression at E12.5±13.5. Robust lacZ expres-
sion was seen in endocardial, epicardial, and sub-
epicardial cells in control or FOG-21/2 hearts (Figures
5Bb and 5Bd). Despite intense lacZ staining in the endo-
cardium of mutant hearts, no expression was detected
in the outer (epicardial or subepicardial) layers (Figure
5Bc and 5Be). These findings provide compelling evi-
dence that the program of coronary vascular formation
is disrupted in the absence of FOG-2.
To determine whether FOG-2 acts in a cell-autono-
mous manner in subepicardal vascular formation, chimeric
mice were generated using FOG-21/2 and FOG-22/2
ES cells tagged with an endothelial cell-expressed
transgene reporter, Tie-2/lacZ (Schlaeger et al., 1997).
Control FOG-21/2/Tie2-lacZ cells readily contributed to
E13.5 endothelium, including blood vessels of the sub-
epicardium (Figure 6Aa). FOG-22/2/Tie2-lacZ cells also
contributed to the subepicardium and its blood vessels
(Figures 6Ab and 6Ac). These blood vessels often ap-
peared smaller and less mature than wild-type or FOG-
21/2/Tie-2-LacZ-derived vessels, possibly as a result of
high-level contribution of FOG-22/2 cells to myocardium
(see below). Nonetheless, this finding indicates that the
FOG-22/2 phenotype is non-cell-autonomous in EPDCs.
Rescue of Coronary Vasculature by FOG-2
Expression in Myocardium
The thin myocardial phenotype of FOG-22/2 hearts was
rescued in chimeras that developed coronary vascula-
ture (Figures 6Ab and 6Ac). Yet, the FOG-22/2 defect
was recapitulated in highly chimeric embryos (data not
shown). We speculated, therefore, that FOG-2 expres-
sion in wild-type cells of chimeric myocardium might
be required to induce the epithelial to mesenchymal
transformation in epicardium.
To address this possibility, we generated transgenic
mice expressing FOG-2 under the control of regulatory
sequences from the MyHCa promoter. This promoter
Figure 4. Coronary Vasculature Abnormality of FOG-22/2 Hearts De-
directs expression specifically to cardiomyocytes inspite Intact Epicardium
atria and ventricles by E10.5 (Subbarayan et al., 2000).
(A) Immunostaining of isolated E12.5 mouse hearts with a-PECAM-1
Transgenic (TG) mice were crossed to FOG-2 heterozy-antibody (ventral view, top; dorsal view, bottom) shows the presence
gotes, and the resultant progeny (TG/FOG-21/2) wereof the endocardial cell network in the ventricles and endothelial cells
lining the great vessels and the atria in the wild-type (1/1, a and
c) and the mutant (2/2, b and d). Capillary vasculature in the control
heart (arrow) is absent in the mutant. Staining illustrates stenosis
of the pulmonary trunk (PT) in FOG-22/2 heart (arrowhead). a-RALDH-2 (a and b), a-endoglin (e and f), or a-WT-1 (g and h)
(B) Unaltered expression of the endothelial/epicardial genes in con- antibodies or RNA in situ hybridization with epicardin probe (c and
trol (1/1, a, c, e, and g) and mutant (2/2, b, d, f, and h) embryos. d) are shown. Epicardial staining is indicated by arrowheads. V,
Sectioned whole-mounts of the isolated mouse hearts stained with ventricle. Original magnification, 1003.
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backcrossed to FOG-21/2 heterozygotes. Litters were
examined at E15.5. Nontransgenic FOG-22/2 embryos
were dead and appeared necrotic, while transgenic
FOG-22/2 (TG/FOG-22/2) embryos were grossly normal
(Figures 6Ba±6Bc). Histological examination revealed
that ventricular wall thinning phenotype was rescued in
TG/FOG-22/2 embryos (Figure 6Bd), although cardiac
morphological abnormalities (i.e., common AV valve)
were still present (data not shown). Immunostaining with
a-Flk-1 antibody demonstrated normal epicardial stain-
ing and coronary vascular development (Figure 6Be).
Hence, expression of FOG-2 in myocardium is sufficient
to correct the thin myocardium and coronary vascular
defects associated with FOG-2 loss.
Discussion
FOG-2 Is Dispensable for Cardiac Commitment
and Differentiation
Overlapping expression of FOG-2 and GATA-4/5/6 in
the developing heart provides a rationale for considering
the requirement for this GATA cofactor in development.
Targeting the FOG-2 gene affords the benefit of eliminat-
ing a cofactor common to multiple GATA proteins. Loss
of FOG-2 though leads to a surprisingly modest effect
on myocardial gene expression. Indeed, ANF and BNP,
which have been considered likely targets of GATA-4
and FOG-2 based on in vitro studies, appear to be
expressed normally in FOG-22/2 hearts. In addition, ex-
pression of other potential GATA-4 (or GATA-5/6) tar-
gets remains unchanged. These observations are un-
likely to be accounted for through compensation by
FOG-1. FOG-1 expression is barely detected in the de-
veloping ventricular myocardium and is not upregulated
in FOG-22/2 embryos (data not shown). Also, in embryos
lacking both FOG-s, hearts undergo looping and con-
tract (unpublished data), suggesting that cardiac lineage
commitment and differentiation proceed. Either in vitro
transfection experiments are poor predictors of in vivo
action on target genes or other mechanisms exist to
account for the expression of multiple GATA-target
genes without FOG-2.
Among the many myocardial-expressed genes sur-
veyed, only the Hand genes appeared to be expressed
Figure 5. Aberrant Epicardial Expression of ICAM-2 and FLK-1 in abnormally in FOG-22/2 hearts. Due to early lethality of
E13.5 FOG-22/2 Hearts Hand null embryos (prior to E10.5) (Firulli et al., 1998;
(A) Staining of E13.5 control and FOG-22/2 hearts with an a-ICAM-2 Riley et al., 1998), Hand protein function at later stages
antibody. (a and b) Well-developed vascular tree in the control heart is undefined. Inadequate expression of Hand genes in
(a) is missing in the mutant (b). Dorsal view is shown. LV, left ventri- the myocardium of FOG-22/2 embryos may contribute
cle; RV, right ventricle. (c and d) Sections of the hearts shown in (a)
to ventricular thinning by reducing the generation orand (b). Staining in the epicardial and subepicardial structures is
survival of the relevant precursor cells. Interpretingindicated by arrowheads in (c).
(B) Aberrant FLK-1 expression in FOG-22/2 embryos. (a) Staining of involvement of FOG-2 in expression of Hand genes
control (left) and FOG-22/2 (right) hearts at E13.5 with an a-FLK-1 awaits an understanding of the regulatory elements con-
antibody (frontal view). Lg, lung; LV and RV, left and right ventricles. trolling their transcription.
Arrow marks stained endothelial cells inside the great vessels. (b-e)
Sections of E13.5 mouse hearts containing LacZ/FLK-1 knockin
FOG-2 Loss Results in Multiple Cardiac Abnormalitiesallele and either a wild-type (b and d) or FOG-22/2 mutant back-
Including Tetralogy of Fallotground (c and e). b-galactosidase staining of the epicardial and
subepicardial structures on the control sections is indicated by ar- Targeted mutations affecting virtually all aspects of
rowheads. Infrequent b-galactosidase-stained cells in the mutant heart development have been described. Ventricular
epicardium are indicated by an arrow in (c). Magnification: (b and septal defects and an overriding aorta have been de-
c), 1003; (d and e), 2003.
scribed in mice with disruptions in the genes for NF1
(neurofibromatosis type 1) (Jacks et al., 1994) and non-
muscle myosin heavy chain (Tullio et al., 1997), as well
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Figure 6. Differential Requirements for FOG-2 in Epicardial Transformation
(A) FOG-2 functions non-cell autonomously in epicardial differentiation. b-galactosidase staining of whole-mount E13.5/E15.5 hearts dissected
from FOG-21/2/Tie2-lacZ (a) and FOG-22/2/Tie2-lacZ (b and c) chimeric embryos. Both FOG-21/2/ and FOG-22/2/Tie2-lacZ cells contribute
to endocardium (E), subepicardium, and blood vessels (arrowheads) of the coronary vasculature. Hearts were stained with a-PECAM-1 antibody
(brown) to confirm identity of blood vessels (c).
(B) FOG-2 expression in the myocardium rescues the coronary vasculature defect. (a±c) Transgenic (TG) FOG-21/2 heterozygous (a), FOG-22/2
mutant (b), and TG/FOG-22/2 (c) E15.5 embryos. Embryo in (c) is grossly normal. (d) High-power (6003) magnification of a ventricular wall
of embryo in (c) showing corrected compact layer and blood-filled subepicardial vessel (arrow). (e) Immunostaining of E15.5 heart of a
TG/FOG-22/2 embryo with a-Flk-1 antibody (dorsal view). Notice the presence of a capillary vascular bed.
as in a subset of animals deficient in neurotrophin 3 observations raise the possibility that gene expression
programs controlled by FOG-2 or GATA factors may(Donovan et al., 1996) and RXRa genes (Gruber et al.,
1996; Lee et al., 1997). It is presently unclear if there is be perturbed in the tetralogy of Fallot syndrome as it
appears in children. As such, FOG-2 and GATA factorscross-talk between FOG-2 and any of these other genes/
proteins; however, the time of death, gross appearance, should be evaluated as candidate genes for congenital
defects in humans (Gelb et al., 1991; Pehlivan et al.,and accompanying defects in FOG-22/2 hearts are dis-
tinctive. 1999).
A striking feature of FOG-22/2 hearts is ventricular
compact layer hypoplasia, also known as ªthin myocar- FOG-2 Is Essential for Development of Coronary
dium syndromeº (Jaber et al., 1996). Similar myocardial Vasculature from Epicardium
phenotypes have been observed upon targeting of the Epicardium in the mouse arises from the mesothelium
genes for transcription factors N-myc, TEF-1, WT-1, and of the septum transversum, the proepicardial organ. Be-
RXRa (for review, see Fishman and Chien, 1997), as well tween E8.5±9, proepicardial cells migrate from the sur-
as the cell surface receptor gp130 (Yoshida et al., 1996), face of the septum transversum to the caudal portion
cell surface kinase bARK-1 (Jaber et al., 1996), and of the primitive ventricles and atria, where they form
erythropoietin and its receptor (Wu et al., 1999). Several patches of epithelial-like cells that fuse to provide a
explanations for this phenotype have been proposed,
including nutritional deficiency (Dyson et al., 1995) and
premature differentiation (Kastner et al., 1994) of cardiac
muscle. Compact layer hypoplasia is not always myo-
cardial cell-autonomous, as conditional gene targeting
of RXRa or gp130 specifically in ventricular myocardium
fails to recapitulate the hypoplastic phenotypes (Chen
et al., 1998; Hirota et al., 1999). Also, it has been shown
that MyHCa-driven RXRa expression in cardiac myo-
cytes fails to rescue hypoplasia or survival of RXRa2/2
mutants (Subbarayan et al., 2000). In contrast, MyHCa-
Figure 7. Arrest in Development of Coronary Vasculature Causeddriven FOG-2 expression rescues ventricular hypoplasia
by FOG-2 Deficiencyand extends the survival of FOG-22/2 fetuses (Fig-
The stages of coronary vascular development are described in Dett-ure 6B).
man et al. (1998). Developmental block imposed by FOG-2 lossIn addition to ventricular thinning, FOG-22/2 hearts
prevents epithelial-to-mesenchymal transition of ªtransformingºare completely penetrant for the tetralogy of Fallot mal-
epicardial cells and subsequent formation of coronary vascular
formation. Although other abnormalities (e.g., thin ven- plexus within the subepicardial space. Molecular interactive signal-
tricular wall and common AV canal) are found in associa- ing between myocardium and epicardium during the transformation
is shown by dotted arrows.tion with this malformation in FOG-22/2 hearts, our
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continuous sheet enveloping the heart (Komiyama et differentiation (Yamaguchi et al., 1993), studies in iso-
al., 1987). Importantly, the proepicardial organ does not lated quail proepicardial organs have demonstrated that
contribute solely to formation of epicardium. Studies of FLK-1 is not expressed until the organ reaches heart
quail-chicken chimera (Poelmann et al., 1993; Dettman myocardium, with expression induced in epicardium-
et al., 1998; Gittenberger-de Groot et al., 1998; Perez- derived cells shortly afterward (Landerholm et al., 1999).
Pomares et al., 1998; Vrancken Peeters et al., 1999), The VEGF/FLK-1 pathway is critical in cardiac develop-
avian retroviral lineage clonal analysis (Mikawa and ment, as elimination of the two of three isoforms of a
Fischman, 1992), and electron microscopy of mouse single VEGF allele restricts myocardial vascularization
embryos (Viragh and Challice, 1981; Komiyama et al., (Carmeliet et al., 1999). Our experiments provide further
1987) suggest that cells of proepicardial origin differenti- evidence of the involvement of VEGF/FLK-1 signaling
ate into at least three different cell types essential for in cardiac vasculogenesis.
coronary vessel development and establishment of the Our chimera analysis and transgenic rescue experi-
intramyocardial circulation. While some cells (a ªpersis- ments establish that the initiation of coronary vascular
tentº population) remain squamous and attached to the development is dependent on FOG-2's function in myo-
surface, a subpopulation of proepicardial and/or epicar- cardium (Figure 7). This finding is consistent with the
dial cells undergoes epithelial to mesenchymal transfor- proposal that the epicardial transformation is controlled
mation, delaminates, and invades the subepicardial by signals emanating from the underlying myocardium
connective tissue and myocardium (Poelmann et al., (similar to segment-specific myocardial induction of
1993; Markwald et al., 1996; Vrancken Peeters et al., atrioventricular (AV) and ouflow tract endocardium into
1999). These cells give rise to the vascular endothelium, cushion mesenchyme) (Markwald et al., 1996; Tomanek,
smooth muscle and cardiac fibroblasts. Recent study 1996; Dettman et al., 1998; Vrancken Peeters et al.,
of chicken-quail chimeras also demonstrates that large 1999). Expression of several growth factors implicated in
numbers of EPDCs colonize myocardium and AV cush- this signaling (e.g., VEGF and angiopoietin-1) in FOG-22/2
ions, including the AV valves (Gittenberger-de Groot et heart appears normal (data not shown). Thus, the iden-
al., 1998). tity of the FOG-2-dependent signals in myocardium re-
Previously described defects in epicardial develop- mains to be elucidated.
ment occur prior to the requisite epithelial to mesenchy- Although our data establish an essential role for FOG-2
mal transformation. An essential role for interaction be- in myocardium, the multiple morphological abnormali-
tween cell adhesion molecules, a4 integrin in the ties evident in FOG-22/2 hearts should not be ascribed
epicardium and VCAM-1 in the myocardium, has been to primary defects limited to this component alone. As
demonstrated (Kwee et al., 1995; Yang et al., 1995). FOG-2 is expressed throughout the developing heart as
In embryos lacking either gene, the epicardial layer is well as in the septum transversum, it is likely to be
missing over large portions of the heart, resulting in active and function in multiple processes . The immature
severe hemorrhage. Absence of the coronary vessels character of cardiac vessels formed by FOG-22/2 endo-
or their precursors in the mutants, as well as myocardial thelium in chimeras, as well as incomplete rescue of
thinning, was noted. These defects resemble cardiac cardiac defects by myocardium-specific expression,
abnormalities of epicardial and subepicardial develop- could be explained by insufficient FOG-2 expression in
ment recently reported in mice deficient for WT-1 (Moore the chimeric or transgenic myocardium, respectively.
et al., 1999). VCAM-1, a4 integrin, and WT-1 are ex- Alternatively, it may relate to additional requirements for
pressed in the hearts of FOG-22/2 mice (Figure 4B; data FOG-2 outside the myocardium. FOG-2 function may
not shown). yet be required in EPDCs to control vessel maturation
The consequences of FOG-2 loss for epicardial devel- and other processes involved in reshaping the primitive
opment are unique and mark the critical step of epithelial embryonic heart into the mature four-chamber organ.
to mesenchymal transformation (Figure 7). In contrast
Molecular mechanisms underlying epicardial differen-
to other phenotypes, FOG-22/2 epicardium is fully able to
tiation and coronary vessel formation have not been
ensheathe the heart, prevent pericardial bleeding, and
elucidated. Our findings provide important insight intoexpress some endothelial/epicardial-specific genes.
how FOG-2- (and, possibly, GATA)-guided pathways in-However, the absence of the developing vascular net-
tersect with VEGF/FLK-1 signaling in morphogenic andwork in the ventricular myocardium as revealed by
vascular development of the heart.PECAM-1 staining, the markedly diminished expression
of vascular markers ICAM-2 and FLK-1, and the inability
to form subepicardial cells indicates an interruption in Experimental Procedures
the normal pathway of epithelial to mesenchymal con-
All recombinant DNA work was done using standard techniques.version.
Details of vectors are available upon request.Our findings with respect to FLK-1 are particularly
insightful. FLK-1, the major receptor for VEGF, is an
important marker of vascular cells and strictly required Targeted Disruption of the Murine FOG-2 Gene
FOG-2 genomic clones were isolated from a lFixII mouse strain 129for vascular development. FLK-12/2 embryos die at
library (Stratagene). To generate a targeting construct, a 4.5 kb SalI-E8.5±9.5 from lethal abnormalities in vasculogenesis,
KpnI fragment containing FOG-2 59 DNA and a 1.6 kb EcoRV-XbaIand FLK-12/2 cells fail to contribute to the endothelial
fragment containing 39 DNA were cloned into pTKLNCL (Tsang et
lineage in chimeric mice (Shalaby et al., 1995, 1997). al., 1998). The targeting construct was linearized with KspI and
FLK-1 gene expression during epicardial differentiation electroporated into CJ-7 ES cells. Two independently generated,
has not been fully explored. Though FLK-1 appears to be targeted ES clones were injected into C57BL/6 blastocysts. Geno-
typing was done by Southern blot analysis.one of the earliest genes expressed during endothelial
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RNase Protection Assays Cornelissen, I., Ehler, E., Kakkar, V.V., Stalmans, I., Mattot, V., et al.
(1999). Impaired myocardial angiogenesis and ischemic cardiomy-RNase protection assays with T2 RNase were performed according
opathy in mice lacking the vascular endothelial growth factor iso-to standard protocol. 32P-labeled FOG-2 antisense probe was gener-
forms VEGF164 and VEGF188. Nat. Med. 5, 495±502.ated from a template containing a 443 bp fragment of FOG-2 (bps
1655±2098 of FOG-2 cDNA). Control 28S rRNA antisense probe Charron, F., and Nemer, M. (1999). GATA transcriptional factors and
was generated from pTRI RNA 28S template (Ambion). The specific cardiac development. Semin. Cell Dev. Biol. 10, 85±91.
protected fragments were 443 and 115 nt for FOG-2 and 28S RNA Chen, J., Kubalak, S.W., and Chien, K.R. (1998). Ventricular muscle-
transcripts, respectively. restricted targeting of the RXRa gene reveals a non-cell-autono-
mous requirement in cardiac chamber morphogenesis. Develop-
In Situ Hybridization and Immunohistochemistry ment 125, 1943±1949.
In situ hybridization with 35S-CTP-labeled riboprobes, whole-mount
Crispino, J.D., Lodish, M.B., MacKay, J.P., and Orkin, S.H. (1999).
hybridization with riboprobes labeled with digoxigenin-UTP (Boeh-
Use of altered specificity mutants to probe a specific protein-protein
ringer Mannheim), TUNEL and PCNA staining, and whole-mount
interaction in differentiation: the GATA-1:FOG complex. Mol. Cell 3,
immunohistochemistry on isolated hearts were performed as pre-
219±228.
viously described (Wilkinson, 1992; Tanaka et al., 1999; Tevosian et
Cubadda, Y., Heitzler, P., Ray, R.P., Bourouis, M., Ramain, P., Gel-al., 1999).
bart, W., Simpson, P., and Haenlin, M. (1997). u-shaped encodes a
zinc finger protein that regulates the proneural genes achaete andStaining for lacZ Expression
scute during the formation of bristles in Drosophila. Genes Dev. 11,Staining of isolated hearts for lacZ expression was performed as
3083±3095.described (Mao et al., 1999). The FLK-1-lacZ strain with lacZ under
Dettman, R.W., Denetclaw, W., Jr., Ordahl, C.P., and Bristow, J.control of the FLK-1 promoter was described (Shalaby et al., 1995).
(1998). Common epicardial origin of coronary vascular smooth mus-The lacZ marker was introduced into the FOG-2 mutant background
cle, perivascular fibroblasts, and intermyocardial fibroblasts in theby interbreeding FLK-1-lacZ and FOG-2 heterozygous mice.
avian heart. Dev. Biol. 193, 169±181.
Donovan, M.J., Hahn, R., Tessarollo, L., and Hempstead, B.L. (1996).Generation and Analysis of Chimeric Embryos
Identification of an essential nonneuronal function of neurotrophinFOG-22/2 cells were isolated by culture of FOG-21/2 ES cells in
3 in mammalian cardiac development. Nat. Genet. 14, 210±213.increased concentration of G418. A 15 kb Tie2-lacZ fragment (which
includes the Tie-2 gene promoter and enhancer, to drive expression Dyson, E., Sucov, H.M., Kubalak, S.W., Schmid-Schonbein, G.W.,
DeLano, F.A., Evans, R.M., Ross, J., Jr., and Chien, K.R. (1995).of lacZ in endothelial cells) was released from pT2HlacZpA1I.7
Atrial-like phenotype is associated with embryonic ventricular failure(Schlaeger et al., 1997) and ligated to a PGK-puromycin cassette
in RXRa2/2 mice. Proc. Natl. Acad. Sci. USA 92, 7386±7390.(1.6 kb) as previously described (Visvader et al., 1998). DNA was
electroporated into FOG-22/2 or FOG-21/2 cells. Puromycin-resis- Fishman, M.C., and Chien, K.R. (1997). Fashioning the vertebrate
tant colonies were analyzed by PCR and Southern blot for presence heart: earliest embryonic decisions. Development 124, 2099±2117.
of the lacZ transgene. Five FOG-21/2/Tie2-lacZ and seven FOG-22/2/ Firulli, A.B., McFadden, D.G., Lin, Q., Srivastava, D., and Olson, E.N.
Tie2-lacZ ES lines were injected into C57BL/6 blastocysts. Three (1998). Heart and extra-embryonic mesodermal defects in mouse
different inputs of cells were introduced to produce a range of chi- embryos lacking the bHLH transcription factor Hand1. Nat. Genet.
merism. Embryos were recovered at E13.5 or E15.5 of development; 18, 266±270.
ES cell contribution was assessed by b-galactosidase staining of
Gao, X., Sedgwick, T., Shi, Y.B., and Evans, T. (1998). Distinct func-
whole-mount hearts. tions are implicated for the GATA-4, 25, and 26 transcription factors
in the regulation of intestine epithelial cell differentiation. Mol. Cell.
Generation of Transgenic Mice Biol. 18, 2901±2911.
For myocardial-specific expression, a 5.5 kb BamHI-SalI fragment
Gelb, B.D., Towbin, J.A., McCabe, E.R., and Sujansky, E. (1991).
of the MyHCa gene (Subramaniam et al., 1991) was cloned into the
San Luis Valley recombinant chromosome 8 and tetralogy of Fallot:
BamHI-SalI site of the pCS21FOG-2 (Tevosian et al., 1999). DNA
a review of chromosome 8 anomalies and congenital heart disease.
was linearized and used for pronuclear microinjection to obtain
Am. J. Med. Genet. 40, 471±476.
MyHCa-FOG-2 transgenic mice.
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